Bank of Nova Scotia’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,124,230
Closed -$47.4M 1086
2023
Q2
$47.4M Buy
1,124,230
+762,413
+211% +$30.8M 0.12% 127
2023
Q1
$12.9M Sell
361,817
-418,847
-54% -$15.2M 0.04% 245
2022
Q4
$28.6M Buy
+780,664
New +$30.9M 0.07% 192
2022
Q1
Sell
-17,455
Closed -$1.79M 1344
2021
Q4
$1.79M Sell
17,455
-66,799
-79% -$6.41M ﹤0.01% 914
2021
Q3
$7.37M Sell
84,254
-27,087
-24% -$2.45M 0.01% 544
2021
Q2
$9.96M Sell
111,341
-47,651
-30% -$4.03M 0.02% 440
2021
Q1
$12.1M Buy
+158,992
New +$12M 0.02% 369

Other funds holding SYNH

Bank of Nova Scotia's SYNH Position: Q3 2023 in Review

Bank of Nova Scotia sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 1,124,230 shares — an estimated $47.4M sold.

Bank of Nova Scotia first reported a position in SYNH in Q1 2021 and held it in 7 quarters. The position peaked at $47.4M in Q2 2023. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Bank of Nova Scotia reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Bank of Nova Scotia sold 1,124,230 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $47.4M.
  • Bank of Nova Scotia first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2021 and held it in 7 quarters.
  • Bank of Nova Scotia's Syneos Health, Inc. Class A Common Stock position peaked at $47.4M in Q2 2023.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Bank of Nova Scotia's 13F filing for Q3 2023, filed 14 Nov 2023.